White label – Pompe disease - ClinicalTrials.eu

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

Not recruiting

3 1 1
Investigated Diseases:
- Short-bowel syndrome
Investigated Drugs:
- Apraglutide
+5
Study of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)

Not recruiting

2 1 1
Investigated Diseases:
- Anaemia
- Myelodysplastic syndrome
Investigated Drugs:
- 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia (in remission)
Investigated Drugs:
- Decitabine
- Venetoclax
Study of Tepotinib and Osimertinib for Patients with Advanced or Metastatic Lung Cancer Resistant to Osimertinib Therapy

Not recruiting

2 1 1 1
Investigated Drugs:
- Osimertinib
- Tepotinib
Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Ocrelizumab
+14
Study of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Waldenstrom’s macroglobulinaemia
Investigated Drugs:
Study Comparing Belantamab Mafodotin with Pomalidomide and Dexamethasone to Bortezomib with Pomalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+1
Study on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

Not recruiting

1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Sunvozertinib
Study on the Safety and Effectiveness of AUTO1 for Adults with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia Using a Drug Combination

Not recruiting

1 1 1 1
Investigated Drugs:
Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

Not recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis relapse
Investigated Drugs:
- Ofatumumab
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies